
Intellia Therapeutics to Present at September Healthcare Investor Conferences
CAMBRIDGE, Mass., Aug. 31, 2021 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage genome editing company focused on developing curative therapeutics using CRISPR/Cas9 technology both in vivo and ex vivo, will present at the following virtual healthcare investor conferences in September: Click here to view original post… […]